Articles
Targeting hard to reach patient populations with brand messages

Targeting hard to reach patient populations with brand messa...

Laura Liotta explains the importance of understanding patient populations before attempting to engage with hard-to-reach patients. Communication is the most important component in a healthy relationship. It is the main ingredient for a successful and long-lasting partnership...

Articles
Rare is different: innovation happens at the margins

Rare is different: innovation happens at the margins

In the final post for 'Rare is different' Wendy White looks at the business environment for developing rare disorder therapies and addresses the role patient communities can play in getting drugs for rare diseases approved and to market. Due to the nature of the condition, a patient diagnosed with any one of the more than 7,000 rare diseases and disorders is part of...

Articles
Device ad-vice: dating vs. commitment: pharma vs. devices

Device ad-vice: dating vs. commitment: pharma vs. devices

In the first of a new series on medical device marketing Nancy Beesley highlights the key ways device marketing is different from pharma marketing. I started in medical advertising more than 20 years ago in a rising star agency that specialized in pharmaceutical marketing...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more